Épisode 62: Étude REDUCE-AMI
Épisode 62: Bêtabloquant post-infarctus du myocarde avec fraction d’éjection préservée (étude REDUCE-AMI)
Diffusé le 17 mai 2024
Dans cette 62e baladodiffusion, le Dr Luc Lanthier discute de l’utilisation des bêtabloquants à la suite d’un infarctus du myocarde, en plus de réviser la littérature médicale d’avril 2024.
Quiz clinique (1 min 52), présentation principale (2 min 20), critique (17 min 20), autres articles (23 min 44), réponse au quiz clinique (26 min 13)
Yndigegn T, Lindahl B, Mars K, Alfredsson J, Benatar J, Brandin L, et al; REDUCE-AMI Investigators. Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. N Engl J Med. 2024;390(15):1372-1381. PubMed PMID: 38587241.
Steg PG. Routine Beta-Blockers in Secondary Prevention - On Injured Reserve. N Engl J Med. 2024;390(15):1434-1436. PubMed PMID: 38587255.
Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-826. PubMed PMID: 37622654.
Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-77. PubMed PMID: 28886621.
O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Jr., Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):529-55. PubMed PMID: 23247303.
Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Jr., Ganiats TG, Holmes DR, Jr., et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(25):2354-94. PubMed PMID: 25249586.
Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366(9497):1622-32. PubMed PMID: 16271643.
Foley MJ, Rajkumar CA, Ahmed-Jushuf F, Simader FA, Chotai S, Pathimagaraj RH, et al. Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial. Lancet. 2024;403(10436):1543-53. PubMed PMID: 38604209.
Moller JE, Engstrom T, Jensen LO, Eiskjaer H, Mangner N, Polzin A, et al. Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock. N Engl J Med. 2024;390(15):1382-93. PubMed PMID: 38587239.
Kosiborod MN, Petrie MC, Borlaug BA, Butler J, Davies MJ, Hovingh GK, et al. Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes. N Engl J Med. 2024;390(15):1394-407. PubMed PMID: 38587233.
Butler J, Jones WS, Udell JA, Anker SD, Petrie MC, Harrington J, et al. Empagliflozin after Acute Myocardial Infarction. N Engl J Med. 2024;390(16):1455-66. PubMed PMID: 38587237.
Bohm F, Mogensen B, Engstrom T, Stankovic G, Srdanovic I, Lonborg J, et al. FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction. N Engl J Med. 2024;390(16):1481-92. PubMed PMID: 38587995.
Meissner WG, Remy P, Giordana C, Maltete D, Derkinderen P, Houeto JL, et al. Trial of Lixisenatide in Early Parkinson's Disease. N Engl J Med. 2024;390(13):1176-85. PubMed PMID: 38598572.
Goltstein L, Grooteman KV, Bernts LHP, Scheffer RCH, Laheij RJF, Gilissen LPL, et al. Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial. Gastroenterology. 2024;166(4):690-703. PubMed PMID: 38158089.
Guerra PG, Simpson CS, Van Spall HGC, Writing P, Asgar AW, et al. Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive. Can J Cardiol. 2024;40(4):500-23. PubMed PMID: 37820870.
van Diepen S, Le May MR, Alfaro P, Goldfarb MJ, Luk A, Mathew R, et al. Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Clinical Practice Update on Optimal Post Cardiac Arrest and Refractory Cardiac Arrest Patient Care. Can J Cardiol. 2024;40(4):524-39. PubMed PMID: 38604702.
Guerra PG, Simpson CS, Van Spall HGC, Writing P, Asgar AW, et al. Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive. Can J Cardiol. 2024;40(4):500-23. PubMed PMID: 37820870.
